» Articles » PMID: 36467410

The Role of Prelamin A Post-translational Maturation in Stress Response and 53BP1 Recruitment

Overview
Specialty Cell Biology
Date 2022 Dec 5
PMID 36467410
Authors
Affiliations
Soon will be listed here.
Abstract

Lamin A is a main constituent of the nuclear lamina and contributes to nuclear shaping, mechano-signaling transduction and gene regulation, thus affecting major cellular processes such as cell cycle progression and entry into senescence, cellular differentiation and stress response. The role of lamin A in stress response is particularly intriguing, yet not fully elucidated, and involves prelamin A post-translational processing. Here, we propose prelamin A as the tool that allows lamin A plasticity during oxidative stress response and permits timely 53BP1 recruitment to DNA damage foci. We show that while PCNA ubiquitination, p21 decrease and H2AX phosphorylation occur soon after stress induction in the absence of prelamin A, accumulation of non-farnesylated prelamin A follows and triggers recruitment of 53BP1 to lamin A/C complexes. Then, the following prelamin A processing steps causing transient accumulation of farnesylated prelamin A and maturation to lamin A reduce lamin A affinity for 53BP1 and favor its release and localization to DNA damage sites. Consistent with these observations, accumulation of prelamin A forms in cells under basal conditions impairs histone H2AX phosphorylation, PCNA ubiquitination and p21 degradation, thus affecting the early stages of stress response. As a whole, our results are consistent with a physiological function of prelamin A modulation during stress response aimed at timely recruitment/release of 53BP1 and other molecules required for DNA damage repair. In this context, it becomes more obvious how farnesylated prelamin A accumulation to toxic levels alters timing of DNA damage signaling and 53BP1 recruitment, thus contributing to cellular senescence and accelerated organismal aging as observed in progeroid laminopathies.

Citing Articles

At the nucleus of cancer: how the nuclear envelope controls tumor progression.

Paganelli F, Poli A, Truocchio S, Martelli A, Palumbo C, Lattanzi G MedComm (2020). 2025; 6(2):e70073.

PMID: 39866838 PMC: 11758262. DOI: 10.1002/mco2.70073.


Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction.

Schena E, Mattioli E, Peres C, Zanotti L, Morselli P, Iozzo P Cells. 2023; 12(22).

PMID: 37998321 PMC: 10670260. DOI: 10.3390/cells12222586.


Role of C-Terminal Phosphorylation of Lamin A in DNA Damage and Cellular Senescence.

Ao Y, Wu Z, Liao Z, Lan J, Zhang J, Sun P Cells. 2023; 12(4).

PMID: 36831305 PMC: 9954792. DOI: 10.3390/cells12040639.

References
1.
Balmus G, Larrieu D, Barros A, Collins C, Abrudan M, Demir M . Targeting of NAT10 enhances healthspan in a mouse model of human accelerated aging syndrome. Nat Commun. 2018; 9(1):1700. PMC: 5923383. DOI: 10.1038/s41467-018-03770-3. View

2.
Pellegrini C, Columbaro M, Capanni C, DApice M, Cavallo C, Murdocca M . All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype. Oncotarget. 2015; 6(30):29914-28. PMC: 4745772. DOI: 10.18632/oncotarget.4939. View

3.
Ragnauth C, Warren D, Liu Y, McNair R, Tajsic T, Figg N . Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation. 2010; 121(20):2200-10. DOI: 10.1161/CIRCULATIONAHA.109.902056. View

4.
Liu Y, Drozdov I, Shroff R, Beltran L, Shanahan C . Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells. Circ Res. 2013; 112(10):e99-109. DOI: 10.1161/CIRCRESAHA.111.300543. View

5.
Filesi I, Gullotta F, Lattanzi G, DApice M, Capanni C, Nardone A . Alterations of nuclear envelope and chromatin organization in mandibuloacral dysplasia, a rare form of laminopathy. Physiol Genomics. 2005; 23(2):150-8. DOI: 10.1152/physiolgenomics.00060.2005. View